March 27, 2026 New findings have provided more evidence that omitting carboplatin from standard neoadjuvant therapy in HER2-positive early
Megan Brooks
Geo Focus
Coverage Attributes:
Beta
Informative:
42
%
Data Driven:
40
%
Cites Data:
10
%
Press Release:
3
%
Government Announcement:
1
%
Themes Covered:
Not enough data
Pitching Insights
Megan's coverage spans a broad range of health and scientific topics, with an emphasis on citing data. She is likely to be receptive to pitches from experts who can provide insights supported by credible data or studies within the healthcare and pharmaceutical fields. Given her focus on specific treatments and therapies, she may also be interested in hearing from medical professionals who have experience implementing these treatments or conducting relevant research.
It seems that Megan doesn't have a specified geographic focus, therefore providing information about global trends or developments in the healthcare industry could capture her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Feature Writer
Most recent topics
Not enough data
